ENTITY

Maze Therapeutics (MAZE US)

11
Analysis
Health CareUnited States
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic diseases, including obesity.
more
Exchange Announcement07 Nov 2025 05:21
Exchange Announcement07 Nov 2025 05:11
Exchange Announcement18 Oct 2025 04:15
Exchange Announcement06 Oct 2025 19:30
x